| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| RenovoRx, Inc. | Director | Stock Options (right to buy) | 47.6K | Oct 1, 2025 | Direct | ||
| Quince Therapeutics, Inc. | Director | Director Stock Option (Right to Buy) | 27K | Jun 4, 2025 | Direct | ||
| Quince Therapeutics, Inc. | Director | Employee Stock Option (right to buy) | 27K | Jun 5, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| RNXT | RenovoRx, Inc. | Oct 1, 2025 | 1 | $0 | 4 | Oct 2, 2025 | Director |
| QNCX | Quince Therapeutics, Inc. | Jun 4, 2025 | 1 | $0 | 4 | Jun 6, 2025 | Director |
| RNXT | RenovoRx, Inc. | Oct 1, 2024 | 1 | $0 | 4 | Oct 2, 2024 | Director |
| QNCX | Quince Therapeutics, Inc. | Jun 5, 2024 | 1 | $0 | 4 | Jun 7, 2024 | Director |
| RNXT | RenovoRx, Inc. | Oct 1, 2023 | 1 | $0 | 4 | Oct 2, 2023 | Director |
| QNCX | Quince Therapeutics, Inc. | May 24, 2023 | 1 | $0 | 4 | May 26, 2023 | Director |
| RNXT | RenovoRx, Inc. | Oct 1, 2022 | 1 | $0 | 4 | Oct 4, 2022 | Director |
| QNCX | Cortexyme, Inc. | Jun 8, 2022 | 1 | $0 | 4 | Jun 9, 2022 | Director |
| RNXT | RenovoRx, Inc. | Mar 10, 2022 | 1 | $0 | 4 | Mar 14, 2022 | Director |
| RNXT | RenovoRx, Inc. | Oct 1, 2021 | 1 | $0 | 4 | Oct 5, 2021 | Director |
| RNXT | RenovoRx, Inc. | Aug 25, 2021 | 0 | $0 | 3 | Aug 25, 2021 | Director |
| QNCX | Cortexyme, Inc. | Jun 16, 2021 | 1 | $0 | 4 | Jun 17, 2021 | Director |